This article is a correction to:
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19
Bindu Adhikari1,2Joseph S. Bednash3
Jeffrey C. Horowitz3Mark P. Rubinstein4,5
Anastasia N. Vlasova1,2*- 1Department of Veterinary Preventive Medicine, College of Veterinary Medicine, The Ohio State University, Wooster, OH, United States
- 2Center for Food Animal Health, Department of Animal Sciences, Ohio Agriculture Research and Development Center (OARDC), College of Food, Agricultural and Environmental Sciences, The Ohio State University, Wooster, OH, United States
- 3Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, OH, United States
- 4Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States
- 5The Pelotonia Institute of Immuno-Oncology, The Ohio State University James Comprehensive Cancer Center, Columbus, OH, United States
A Corrigendum on
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19
By Adhikari B, Bednash JS, Horowitz JC, Rubinstein MP and Vlasova AN (2024) Front. Immunol. 15:1325243. doi: 10.3389/fimmu.2024.1325243
In the published article, there was an error. The authors cited a previous publication in a way that can be misinterpreted if taken out of context.
A correction has been made to Discussion, paragraph 1, page 4.
This sentence previously stated:
“Of special relevance to our data (Supplementary Figure 1), Piotr Rzymski et al. reported that (9), counterintuitively, mortality rates increased with additional vaccine doses and increased postvaccination time”.
The corrected sentence appears below:
“Of special relevance to our data (Supplementary Figure 1), Piotr Rzymski et al. reported that (9) among subgroups of Vax hospitalized patients (representing 1% of all hospitalized), mortality rates increased with additional vaccine doses and increased post-vaccination time (although deceased Vax patients represented only 0.2% of all hospitalized patients and 1% of all deceased individuals in the studied period).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: SARS-CoV-2, mortality, antibodies, IgG4, immune tolerance, comorbidities, COVID-19 vaccines
Citation: Adhikari B, Bednash JS, Horowitz JC, Rubinstein MP and Vlasova AN (2024) Corrigendum: Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19. Front. Immunol. 15:1384209. doi: 10.3389/fimmu.2024.1384209
Received: 08 February 2024; Accepted: 12 February 2024;
Published: 28 February 2024.
Edited and Reviewed by:
Pei-Hui Wang, Shandong University, ChinaCopyright © 2024 Adhikari, Bednash, Horowitz, Rubinstein and Vlasova. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Anastasia N. Vlasova, vlasova.1@osu.edu